| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 231.69B | 229.21B | 195.94B | 186.79B | 162.44B | 150.37B |
| Gross Profit | 77.79B | 77.40B | 56.48B | 54.44B | 51.13B | 45.05B |
| EBITDA | 23.00B | 23.04B | 10.18B | 13.33B | 15.72B | 12.85B |
| Net Income | 12.26B | 13.32B | 2.70B | 7.39B | 8.91B | 7.16B |
Balance Sheet | ||||||
| Total Assets | 250.58B | 262.17B | 228.43B | 212.08B | 196.84B | 184.51B |
| Cash, Cash Equivalents and Short-Term Investments | 13.48B | 35.59B | 18.33B | 14.97B | 16.15B | 10.88B |
| Total Debt | 53.46B | 60.78B | 46.73B | 44.78B | 43.73B | 43.90B |
| Total Liabilities | 108.23B | 115.78B | 97.55B | 90.12B | 86.54B | 83.16B |
| Stockholders Equity | 140.33B | 144.20B | 129.06B | 120.21B | 108.61B | 99.98B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.62B | 3.97B | 807.00M | 4.80B | 7.68B |
| Operating Cash Flow | 0.00 | 18.92B | 10.01B | 5.82B | 11.57B | 13.73B |
| Investing Cash Flow | 0.00 | -9.13B | -6.82B | -3.28B | -7.26B | -4.28B |
| Financing Cash Flow | 0.00 | 6.88B | -453.00M | -2.04B | -2.36B | -7.86B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥87.73B | 5.77 | 15.07% | 1.74% | 15.12% | 40.72% | |
80 Outperform | ¥21.73B | 9.84 | ― | 1.82% | -7.26% | ― | |
76 Outperform | ¥79.99B | 6.04 | ― | 3.04% | 1.57% | -33.97% | |
73 Outperform | ¥120.13B | 25.17 | 5.56% | 2.59% | 2.58% | -3.16% | |
73 Outperform | ¥123.10B | 26.50 | ― | 3.77% | 9.07% | 152.79% | |
62 Neutral | ¥25.53B | 9.97 | ― | 4.27% | 5.72% | 28.92% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |